Tekla Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-265,045
| Closed | -$7.54M | – | 181 |
|
|
2018
Q1 | $7.54M | Hold |
265,045
| – | – | 0.29% | 76 |
|
|
2017
Q4 | $5.6M | Sell |
265,045
-265,047
| -50% | -$5.6M | 0.22% | 82 |
|
|
2017
Q3 | $9.63M | Hold |
530,092
| – | – | 0.34% | 53 |
|
|
2017
Q2 | $8.22M | Hold |
530,092
| – | – | 0.3% | 64 |
|
|
2017
Q1 | $9.16M | Sell |
530,092
-225,998
| -30% | -$3.9M | 0.36% | 63 |
|
|
2016
Q4 | $8.31M | Hold |
756,090
| – | – | 0.35% | 63 |
|
|
2016
Q3 | $11.9M | Hold |
756,090
| – | – | 0.46% | 50 |
|
|
2016
Q2 | $7.72M | Buy |
756,090
+428,031
| +130% | +$4.37M | 0.32% | 68 |
|
|
2016
Q1 | $4.23M | Hold |
328,059
| – | – | 0.18% | 94 |
|
|
2015
Q4 | $6.85M | Buy |
+328,059
| New | +$6.85M | 0.25% | 76 |
|